Vice versa, pharmacological inhibition of NPC1 strongly reduces infection with SARS-CoV-2 [54] and interferes with the fusion of viral envelopes with late endosomal membranes [55,56,57] (Figure 1). This evidence concerns the gene NPC1 and infection.